SEC Form 4 · accession 0001209191-16-149538
VERTEX PHARMACEUTICALS INC / MA · VRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul M Silva
Officer — SVP & Corp Controller
Period of report
Nov 9, 2016
Accepted (ET)
Nov 14, 2016 · 8:39 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875320
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 9, 2016 | M | 3,375 | $37.86 | A | 17,125 | D | |
| Common Stock | Nov 10, 2016 | M | 1,687 | $45.11 | A | 18,812 | D | |
| Common Stock | Nov 9, 2016 | S | 3,375 | $88.92 | D | 15,437 | D | |
| Common Stock | Nov 10, 2016 | S | 1,687 | $95.11 | D | 13,750 | D | |
| Common Stock | holding | — | — | — | 169 | I | 401k |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $37.86 | Nov 9, 2016 | M | 3,375 | D | — | Feb 1, 2022 | Common Stock | 3,375 | 0 | D |
| Stock Option (Right to Buy)F3 | $45.11 | Nov 10, 2016 | M | 1,687 | D | — | Feb 4, 2023 | Common Stock | 1,687 | 10,126 | D |
Explanation of responses
- F1Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.
- F2Fully vested.
- F3The option vests in 16 quarterly installments from 02/05/2013.